The U.S. biochip product & services market is estimated to be valued at US$ 7.6 billion in 2023 and is expected to exhibit a CAGR of 10.6% during the forecast period (2023-2030).
Figure 1. U.S. Biochip Product & Services Market Share (%), by Product Type, 2023
Biochip Products are used for diagnosis of infectious diseases, respiratory diseases, cancer, and for personalized treatment. There are three types of biochips namely DNA microarray, protein microarray, and microfluidic chip. Increasing number of clinical trials along with technological advancements of biochips are expected to aid in the growth of the market. Furthermore, increasing product approvals and increasing incidence of chronic diseases is also expected to assist the growth of the market during the forecasted period.
Figure 2. . U.S. Biochip Product & Services Market Share (%), by Application, 2023
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients